Patents
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
02/1994
02/17/1994CA2140883A1 Asymmetrically substituted xanthines
02/16/1994CN1082047A 8-(1-aminocycloalkyl_-1,3-dialkylxanthine derivatives, preparation process and antidepressant, nootropic and psychostimulant composition thereof
02/16/1994CN1023804C Novel acetylenic, cyano and allenic aristeromycin/adenosine derivatives
02/15/1994CA1327000C Antiviral therapy for hepatitis b
02/08/1994US5284837 Viricides
02/08/1994CA1326849C Treatment of malignant tumors with 8 chloroadenosine 3',5'-cyclic phosphate, and preparation thereof
02/03/1994WO1994002483A1 Tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents
02/03/1994WO1994002150A1 Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
02/03/1994CA2140662A1 Tetracyclic compounds, process and intermediates for their preparation and their use as antitumour agents
02/02/1994EP0581166A1 Benzimidazoles, process for their preparation and their use as angiotensin-II antagonists
02/02/1994EP0580892A1 Process for recovery of caffeine from activated carbon
02/02/1994EP0580657A1 Use of guanine derivative or a prodrug thereof in the treatment of hiv-1 infection
02/01/1994CA2100696A1 Process for recovery of caffeine from activated carbon
01/1994
01/26/1994EP0579643A1 Atp analogues
01/25/1994US5281605 Pharmaceuticals
01/23/1994CA2100927A1 Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
01/20/1994WO1994001413A1 Boronated compounds
01/20/1994WO1994001114A1 Antidepressant
01/19/1994EP0579421A2 Process for preparing guanine-containing antiviral agents and purinyl salts useful in such process
01/19/1994CN1023561C Process for preparing aristeromycin/adenosine derivatives
01/18/1994US5280009 Substituted pyrimidine derivatives and their use for controlling undesirable plant growth
01/18/1994CA1326237C Therapeutic nucleosides
01/14/1994CA2098033A1 Process for preparing cyclobutane purines
01/12/1994EP0578208A1 Process for the preparation of 2-fluoro-9-(2,3,5-tri-O-benzyl-beta-arabinofuranozyl)adenine
01/12/1994EP0577788A1 Insect control with substituted oxadiazole and thiadiazole compounds
01/11/1994US5278165 Oxazolyl imidazol[4,5-b]pyridin and pyrimidine compounds
01/06/1994WO1994000453A1 Purinone antianginal agents
01/06/1994WO1994000452A1 7-neopentyl xanthine derivatives, their preparation and pharmaceutical compositions containing them
01/05/1994EP0577558A2 Carbocyclic nucleosides having bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates
01/05/1994CN1080290A Comprehensive utilization method of tea waste
01/04/1994US5276150 1,4-dihydropyridine derivatives
01/04/1994US5276020 Anti-virals
01/02/1994CA2099712A1 Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates
12/1993
12/28/1993US5274157 Protected formylpentanediols, hydroxymethylpentanediols, process for their preparation and intermediates
12/23/1993WO1993025565A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof
12/23/1993CA2138415A1 1,5-anhydrohexitol nucleoside analogues and pharmaceutical use thereof
12/22/1993EP0574386A1 Novel process for the preparation of nucleotides
12/21/1993US5272167 Pharmaceutically active compounds
12/21/1993US5272152 Purinyl and pyrimidinyl tetrahydrofurans
12/21/1993US5272150 Hydroxyalkylfuranyl derivatives
12/15/1993EP0573617A1 Modulation of cellular response to external stimuli
12/14/1993US5270315 4-(purinyl bases)-substituted-1,3-dioxlanes
12/09/1993WO1992021344A3 Modulation of cellular response to external stimuli
11/1993
11/30/1993US5266570 Piperidine derivatives, compositions and use
11/25/1993WO1993023413A1 Synthesis of nucleotide monomers
11/25/1993WO1993023401A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993WO1993023399A1 6-AMINO SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS ANGIOTENSIN II ANTAGONISTS
11/25/1993WO1993023396A1 Fused imidazole and triazole derivatives as 5-ht1 receptor agonists
11/25/1993WO1993023392A1 Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
11/25/1993WO1993017684A3 Enantiomeric hydroxylated xanthine compounds
11/25/1993DE4316882A1 DNA contg. caffeine de-methylase gene - used in prodn. of 3-methyl-7-alkyl-xanthine cpds. by microbial demethylation of 1,3-di:methyl derivs.
11/25/1993CA2136196A1 8-substituted anthines as phosphodiesterase inhibitors
11/25/1993CA2135498A1 Synthesis of nucleotide monomers
11/25/1993CA2135188A1 6-amino substituted imidazo(4,5-b)pyridines as angiotensin ii antagonists
11/25/1993CA2134986A1 Fused imidazole and triazole derivatives as 5-htl receptor agonists
11/24/1993EP0570831A2 Use of Xanthinderivatives for treatment of cerebral nerve dammages after disruption of the blood circulation
11/24/1993EP0570519A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/23/1993US5264573 Process for preparing 2-chloro-1,7-dihydropurin-6-one and a process for its purification
11/23/1993US5264561 Method of manufacturing 2',3'-dideoxy-2',3'-didehydronucleosides
11/18/1993EP0569421A1 Pharmaceuticals.
11/11/1993WO1993021783A1 Methods of treating obesity with purine related compounds
11/11/1993CA2134657A1 Methods of treating obesity with purine related compounds
11/09/1993US5260437 Combustion, water scrubbing
11/09/1993US5260322 Angiotension II antagonists in the treatment of hyperuricemia
11/09/1993CA1324131C 2-(heterocyclylalkyl)imidazopyridines
11/02/1993US5258380 (4-piperidinylmethyl and -hetero)purines
10/1993
10/28/1993WO1993020825A1 Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and an s-phase or m-phase specific antineoplastic agent
10/28/1993DE4213064A1 Theophylline recovery from tabletting dust - by extraction with aq. ammonia, used as diuretic
10/27/1993EP0574386A4 Novel process for the preparation of nucleotides.
10/26/1993US5256806 Intermediates for the preparation of optically active cyclobutane nucleoside
10/26/1993US5256650 Hypotensive, antispasmodic agents; sedatives; vasodilation
10/20/1993CN1077454A 2-amino-7-((1,3-dihydroxy-2-propoxy) methyl) purine carboxylate, their process of preparation and use
10/19/1993US5254539 Method of treating HIV with 2',3'-dideoxyinosine
10/14/1993WO1993020078A1 Pharmaceutically active bicyclic-heterocyclic amines
10/14/1993CA2130937A1 Pharmaceutically active bicyclic-heterocyclic amines
10/13/1993EP0565377A1 Therapeutic agents for use in the treatment of parkinson's disease
10/13/1993CN1022414C Process for preparing cyclic buttane derivatives
10/12/1993US5252575 Antiviral purine derivatives with improved gastrointestinal absorption
10/12/1993US5252569 6-substituted purinyl piperazine derivatives
10/06/1993EP0564006A2 Process for preparing purine derivatives and novel purine derivatives
10/06/1993EP0563814A2 Carbonic acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purines, their preparation and their use as antiviral agents
10/06/1993EP0563168A1 Xanthine derivatives
10/05/1993US5250688 Purine derivatives
10/05/1993US5250535 Herpes virus; nontoxic; side effect reduction; humans and veterinary medicine
09/1993
09/30/1993WO1993019060A1 Isoindazole compound
09/30/1993WO1993018789A1 Non-azo naphthalimide dyes and uses for same
09/30/1993CA2109932A1 Isoindazole compound
09/29/1993EP0562009A1 ENANTIOMERICALLY PURE $g(b)-D-(-)-DIOXOLANE-NUCLEOSIDES
09/29/1993CN1022248C Novel 2'-halomethylidene, uridine and guanosine drivatives
09/29/1993CA2092770A1 Carboxylic acid esters of 2-amino-7-/(1,3-dihydroxy-2-propoxy)methyl/purine, their preparation and their use
09/28/1993US5248776 Process for enantiomerically pure β-L-1,3-oxathiolane nucleosides
09/28/1993US5248770 Molecular probes for adenosine receptors
09/28/1993US5248681 Antiinflammatory agents
09/21/1993US5246937 Viricides, herpes simplex
09/21/1993US5246931 Carbocyclic nucleoside analogs
09/16/1993WO1993018035A1 Angiotensin ii receptor antagonists
09/16/1993WO1993017684A2 Enantiomeric hydroxylated xanthine compounds
09/15/1993EP0560407A1 Pharmaceutically active compounds
09/15/1993EP0560354A1 Xanthine derivatives
09/15/1993EP0560330A2 Substituted benzimidazolyl derivatives, therapeutic agents containing them and process for their preparation